Health Trials

MpMRI

2

Review clinical trials related to MpMRI. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI

Bladder cancer is a prevalent malignancy globally, with muscle-invasive disease having a five-year survival rate below 50%. Neoadjuvant chemotherapy (NAC) before radical cystectomy has shown efficacy for resectable muscle-invasive bladder cancer (MIBC). However, non-response to NAC can lead to delayed surgery and unnecessary toxicity. Magnetic resonance imaging (MRI), particularly multiparametric MRI (mpMRI) with dynamic contrast-enhanced (DCE) and diffusion-weighted imaging (DWI), offers functional and quantitative biomarkers that may predict NAC response early in treatment.

Participants needed: 39
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Oct 2, 2025Locations: 1
Eligibility criteria

Patients diagnosed with cT2-T4 urothelial carcinoma of the urinary bladder, acco... [+2]

Patients who have received pelvic radiotherapy. [+5]

Read more
Status: Not yet recruiting

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

The present study is designed to explore the value of targeted puncture guided by PSMA PET/CT or mpMRI in the diagnosis of patients with low PSA and initial negative prostate biopsy

Participants needed: 120
Trial details
Age: 40+Biological sex: MaleType: InterventionalSponsor: Nanjing First Hospital, Nanjing Medical UniversityUpdated: Mar 30, 2025Locations: 1
Eligibility criteria

Age ≥40 years, male; [+4]

Serum PSA >20 ng/mL; [+6]

Read more